Similarly, in the MC38 hot tumor mouse model, CCL20 and IL-1β also drove ILC3s infiltration and lymphocytes recruitment to inhibit tumor growth and also enhanced the reactivity to ICB including anti-PD-1 and anti-CTLA-4, significantly extending the survival rate. This evidence concerns the gene CCL20 and neoplasm.